1 July 2019 in ACM Transactions on Computer-Human Interaction
The notion of interaction is essential to human-computer interaction, yet rarely studied. We use quantitative and qualitative methods to investigate how this notion has been used across 35 years of proceedings from the ACM Conference on Human Factors in Computing (CHI). Using natural language processing, we extract 53,568 occurrences of the word “interaction” across 4,604 papers. In these occurrences, we categorize 2,668 unique words that modify how “interaction” is used in a sentence. We show that the use of “interaction” is both increasing and diversifying, suggesting the importance of the notion, but also the difficulty in developing theory about interaction. Our findings show that styles of interaction are closely associated with changes in technology and that modalities and characteristics of interaction are becoming more of a topic than specific devices or widgets. Interaction qualities, relating to structure, feel, effectiveness, and efficiency, are consistently prominent, and the quality of novelty is increasingly frequent. From this analysis, we identify open questions about interaction, including how to build knowledge across changing technologies, how to work toward a model of quality for interaction, and what the core of a science of interaction could be.
17 April 2023 in European Neuropsychopharmacology
The objective of this study is to quantify the impact of the COVID-19 pandemic on attention deficit hyperactivity disorder (ADHD) medication consumption globally and nationally using pharmaceutical sales data from 2014 to 2021 across 47 countries and regions. A seasonal autoregressive integrated moving average model (SARIMA) was applied to the time series until the end of 2019 at country level and used for the prediction of the ADHD medication consumption in 2020 and 2021. The deviations from the actual to the forecasted sales, which simulate the development without the emergence of COVID-19, yield estimates for the pandemic's impact. In 36 of the 47 countries and regions, the actual sales in 2020 were lower than predicted, with an average relative drop of 6.2% in defined daily doses (DDD) per 1000 inhabitants per day at country-level. In 2021, most countries recorded actually higher ADHD medication use than predicted at the end of 2019. On average, the consumption increased per country by 1.60%. The deviations strongly correlate with the stringency of anti-pandemic government policies. The findings suggest that the pandemic led to a substantially lower consumption of ADHD medication in 2020. However, in 2021 the pandemic had an accelerating effect as the increasing consumption trends are more pronounced than before the pandemic.